130 related articles for article (PubMed ID: 1691716)
1. [The anti-arrhythmia action of combinations of N-propylajmaline bromide with anti-arrhythmia agents of different classes].
Gendenshteĭn EI; Balashov VP; Kostin IaV; Oleĭnikov VE
Farmakol Toksikol; 1990; 53(1):30-2. PubMed ID: 1691716
[TBL] [Abstract][Full Text] [Related]
2. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV
Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754
[TBL] [Abstract][Full Text] [Related]
3. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium].
Gendenshteĭn EI; Balashov VP; Sosunov EA; Kostin IaV; Oleĭnikov VE
Farmakol Toksikol; 1991; 54(4):30-3. PubMed ID: 1786818
[TBL] [Abstract][Full Text] [Related]
4. [Combined action of anti-arrhythmia agents].
Gendenshteĭn EI; Kostin IaV; Balashov VP; Oleĭnikov VE
Biull Eksp Biol Med; 1991 Jun; 111(6):623-5. PubMed ID: 1893190
[TBL] [Abstract][Full Text] [Related]
5. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
[No Abstract] [Full Text] [Related]
6. [Effect of tetrodotoxin and ethmozine on arrhythmias of a dog heart isolated in the late stage of experimental myocardial infarct].
Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG; Dremin SA
Biull Eksp Biol Med; 1980 Oct; 90(10):446-8. PubMed ID: 6159013
[TBL] [Abstract][Full Text] [Related]
7. [Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct].
Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG
Biull Eksp Biol Med; 1981; 91(1):38-40. PubMed ID: 6163491
[TBL] [Abstract][Full Text] [Related]
8. [Hyperergic reaction of the liver after administration of ajmaline and its analog N-propylajmaline].
Matusewicz W; Fronczak A; Krykowski E
Kardiol Pol; 1988; 31(1):66-8. PubMed ID: 2457729
[No Abstract] [Full Text] [Related]
9. [Evaluation with dynamic electrocardiography of the activity of prajmalium bitartrate in patients with ventricular extrasystole and prior myocardial infarct].
Balboni A; Bellotti L; Scaramuzzino G; Cicerone F; Di Biase G
Minerva Cardioangiol; 1983 Sep; 31(9):523-8. PubMed ID: 6199691
[No Abstract] [Full Text] [Related]
10. [Prajmaline in the treatment of arrhythmia].
Tkaczewski W; Goch JH; Ryniec A
Pol Tyg Lek; 1981 Jul; 36(30):1145-7. PubMed ID: 6171802
[No Abstract] [Full Text] [Related]
11. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
[TBL] [Abstract][Full Text] [Related]
12. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
Antoni H; Weirich J
Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
[TBL] [Abstract][Full Text] [Related]
13. [Anti-arrhythmic effect of tetrodotoxin in the late stage of experimental myocardial infarct].
Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG; Dremin SA
Biull Eksp Biol Med; 1979 Oct; 88(10):402-4. PubMed ID: 91393
[TBL] [Abstract][Full Text] [Related]
14. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
Dupuis BA; Vincent AC
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
Femmer K; Grünheid K
Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
[No Abstract] [Full Text] [Related]
16. [Prajmalium bitartrate in hyperkinetic ventricular arrhythmias in infarct patients during rehabilitation].
Molinis G; Valente M; Tuniz D; Maisano G
G Ital Cardiol; 1981; 11(6):749-57. PubMed ID: 7319182
[TBL] [Abstract][Full Text] [Related]
17. [Intrahepatic cholestasis and aplastic anemia following administration of prajmaline].
Lenzen R; Gottesbüren H; Borchard F; Wienbeck M; Strohmeyer G
Klin Wochenschr; 1988 Mar; 66(6):264-70. PubMed ID: 2452916
[TBL] [Abstract][Full Text] [Related]
18. [Bonnecor--a new anti-arrhythmia preparation].
Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
[TBL] [Abstract][Full Text] [Related]
19. [The anti-arrhythmia activity of quinazopyrine].
Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
[TBL] [Abstract][Full Text] [Related]
20. [Medical treatment of extrasystole and tachycardia (author's transl)].
Theisen K; Jahrmärker H
MMW Munch Med Wochenschr; 1980 Jan; 122(3):87-94. PubMed ID: 6154235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
